302 related articles for article (PubMed ID: 25911380)
21. The biology of A20-binding inhibitors of NF-kappaB activation (ABINs).
Verstrepen L; Carpentier I; Beyaert R
Adv Exp Med Biol; 2014; 809():13-31. PubMed ID: 25302363
[TBL] [Abstract][Full Text] [Related]
22. Functional dichotomy of A20 in apoptotic and necrotic cell death.
Storz P; Döppler H; Ferran C; Grey ST; Toker A
Biochem J; 2005 Apr; 387(Pt 1):47-55. PubMed ID: 15527421
[TBL] [Abstract][Full Text] [Related]
23. Nuclear factor-kappaB regulates beta-cell death: a critical role for A20 in beta-cell protection.
Liuwantara D; Elliot M; Smith MW; Yam AO; Walters SN; Marino E; McShea A; Grey ST
Diabetes; 2006 Sep; 55(9):2491-501. PubMed ID: 16936197
[TBL] [Abstract][Full Text] [Related]
24. A20 blocks endothelial cell activation through a NF-kappaB-dependent mechanism.
Cooper JT; Stroka DM; Brostjan C; Palmetshofer A; Bach FH; Ferran C
J Biol Chem; 1996 Jul; 271(30):18068-73. PubMed ID: 8663499
[TBL] [Abstract][Full Text] [Related]
25. A20 zinc finger protein inhibits TNF and IL-1 signaling.
Jäättelä M; Mouritzen H; Elling F; Bastholm L
J Immunol; 1996 Feb; 156(3):1166-73. PubMed ID: 8557994
[TBL] [Abstract][Full Text] [Related]
26. Functional redundancy of the zinc fingers of A20 for inhibition of NF-kappaB activation and protein-protein interactions.
Klinkenberg M; Van Huffel S; Heyninck K; Beyaert R
FEBS Lett; 2001 Jun; 498(1):93-7. PubMed ID: 11389905
[TBL] [Abstract][Full Text] [Related]
27. Identification of a novel A20-binding inhibitor of nuclear factor-kappa B activation termed ABIN-2.
Van Huffel S; Delaei F; Heyninck K; De Valck D; Beyaert R
J Biol Chem; 2001 Aug; 276(32):30216-23. PubMed ID: 11390377
[TBL] [Abstract][Full Text] [Related]
28. Spontaneous NF-κB activation by autocrine TNFα signaling: a computational analysis.
Pękalski J; Zuk PJ; Kochańczyk M; Junkin M; Kellogg R; Tay S; Lipniacki T
PLoS One; 2013; 8(11):e78887. PubMed ID: 24324544
[TBL] [Abstract][Full Text] [Related]
29. Frequent inactivation of A20 in B-cell lymphomas.
Kato M; Sanada M; Kato I; Sato Y; Takita J; Takeuchi K; Niwa A; Chen Y; Nakazaki K; Nomoto J; Asakura Y; Muto S; Tamura A; Iio M; Akatsuka Y; Hayashi Y; Mori H; Igarashi T; Kurokawa M; Chiba S; Mori S; Ishikawa Y; Okamoto K; Tobinai K; Nakagama H; Nakahata T; Yoshino T; Kobayashi Y; Ogawa S
Nature; 2009 Jun; 459(7247):712-6. PubMed ID: 19412163
[TBL] [Abstract][Full Text] [Related]
30. Downstream activation of NF-κB in the EDA-A1/EDAR signalling in Sjögren's syndrome and its regulation by the ubiquitin-editing enzyme A20.
Sisto M; Barca A; Lofrumento DD; Lisi S
Clin Exp Immunol; 2016 May; 184(2):183-96. PubMed ID: 26724675
[TBL] [Abstract][Full Text] [Related]
31. Zinc-suppressed inflammatory cytokines by induction of A20-mediated inhibition of nuclear factor-κB.
Prasad AS; Bao B; Beck FW; Sarkar FH
Nutrition; 2011; 27(7-8):816-23. PubMed ID: 21035309
[TBL] [Abstract][Full Text] [Related]
32. Aberrant Low Expression of A20 in Tumor Necrosis Factor-α-stimulated SLE Monocytes Mediates Sustained NF-κB Inflammatory Response.
Shi X; Qian T; Li M; Chen F; Chen Y; Hao F
Immunol Invest; 2015; 44(5):497-508. PubMed ID: 26107748
[TBL] [Abstract][Full Text] [Related]
33. A20 overexpression inhibits lipopolysaccharide-induced NF-κB activation, TRAF6 and CD40 expression in rat peritoneal mesothelial cells.
Zou XL; Pei DA; Yan JZ; Xu G; Wu P
Int J Mol Sci; 2014 Apr; 15(4):6592-608. PubMed ID: 24747594
[TBL] [Abstract][Full Text] [Related]
34. Expression of the nuclear factor-κB inhibitor A20 is altered in the cystic fibrosis epithelium.
Kelly C; Williams MT; Mitchell K; Elborn JS; Ennis M; Schock BC
Eur Respir J; 2013 Jun; 41(6):1315-23. PubMed ID: 23018911
[TBL] [Abstract][Full Text] [Related]
35. Adenovirus-mediated expression of a dominant negative mutant of p65/RelA inhibits proinflammatory gene expression in endothelial cells without sensitizing to apoptosis.
Soares MP; Muniappan A; Kaczmarek E; Koziak K; Wrighton CJ; Steinhäuslin F; Ferran C; Winkler H; Bach FH; Anrather J
J Immunol; 1998 Nov; 161(9):4572-82. PubMed ID: 9794384
[TBL] [Abstract][Full Text] [Related]
36. A20 inhibits human salivary adenoid cystic carcinoma cells invasion via blocking nuclear factor-kappaB activation.
Zhang B; Guan CC; Chen WT; Zhang P; Yan M; Shi JH; Qin CL; Yang Q
Chin Med J (Engl); 2007 Oct; 120(20):1830-5. PubMed ID: 18028781
[TBL] [Abstract][Full Text] [Related]
37. Deubiquitinating enzyme A20 negatively regulates NF-κB signaling in skeletal muscle in mdx mice.
Charan RA; Hanson R; Clemens PR
FASEB J; 2012 Feb; 26(2):587-95. PubMed ID: 22012122
[TBL] [Abstract][Full Text] [Related]
38. Histone methyltransferase Ash1l suppresses interleukin-6 production and inflammatory autoimmune diseases by inducing the ubiquitin-editing enzyme A20.
Xia M; Liu J; Wu X; Liu S; Li G; Han C; Song L; Li Z; Wang Q; Wang J; Xu T; Cao X
Immunity; 2013 Sep; 39(3):470-81. PubMed ID: 24012418
[TBL] [Abstract][Full Text] [Related]
39. Combined expression of A1 and A20 achieves optimal protection of renal proximal tubular epithelial cells.
Kunter U; Daniel S; Arvelo MB; Choi J; Shukri T; Patel VI; Longo CR; Scali ST; Shrikhande G; Rocha E; Czismadia E; Mottley C; Grey ST; Floege J; Ferran C
Kidney Int; 2005 Oct; 68(4):1520-32. PubMed ID: 16164629
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of tumor necrosis factor-induced necrotic cell death by the zinc finger protein A20.
Heyninck K; Denecker G; De Valck D; Fiers W; Beyaert R
Anticancer Res; 1999; 19(4B):2863-8. PubMed ID: 10652565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
